Abbott Laboratories
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Asset Breakdown FY2022
Total Assets: $74.44B
Liabilities Breakdown FY2022
Total Liabilities: $37.75B
Asset Breakdown
Total Assets: $74.44B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $9.88B | 13.3% |
| Accounts Receivable | $6.22B | 8.4% |
| Inventory | $6.17B | 8.3% |
| Property, Plant & Equipment | $9.16B | 12.3% |
| Goodwill | $22.80B | 30.6% |
| Intangible Assets | $10.45B | 14.0% |
| Other Assets | $9.75B | 13.1% |
Liabilities Breakdown
Total Liabilities: $37.75B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.61B | 12.2% |
| Long-Term Debt | $14.52B | 38.5% |
| Other Liabilities | $18.62B | 49.3% |